Schedule 13G ownership disclosure
Myriad Genetics Inc
Common Stock, par value $0.01 per share · CUSIP: 62855J104
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Camber Capital Management LP
Shares: 3,100,000 · Class: 3.41%
- Stephen DuBois
Shares: 3,100,000 · Class: 3.41%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001654954-25-001501
- Form type
- SCHEDULE 13G/A
- Filer
- Camber Capital Management LP
- CIK
- CIK 1444043
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership